Schedule 13D ownership disclosure

CAMP4 Therapeutics Corp.

Security class unavailable · CUSIP: 13463J101

Event date: 2024-10-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,785,802
Percent of class
19.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-110566
Form type
SC 13D
Filer
Camp4 Therapeutics Corp
CIK
CIK 1736730
Filed
Oct 22, 2024
Reporting period
Oct 15, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub